Amylyx Pharmaceuticals, Inc.
AMLXNASDAQHealthcareDrug Manufacturers - Specialty & Generic
As of Oct 23, 2026 close
- Market cap
- $3.02B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $10.83$41.14
- Volume (live)
- -
- Avg. volume (3M)
- 1.38M
Amylyx Pharmaceuticals (AMLX) Stock Price & Financial Analysis
Amylyx Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $27.06 - $28.46 |
|---|---|
| 52-Week High | $41.14 |
| 52-Week Low | $10.83 |
| Open | $28.46 |
| Volume (last close) | 1.16M |
| Average Volume (3M) | 1.38M |
| 50-Day MA | $30.90 |
|---|---|
| 200-Day MA | $19.44 |
| 1-Year Change | +99.65% |
| Market Cap | 3.02B |
|---|---|
| Shares Outstanding | 111.20M |
| Price to Book (P/B) | 12.65 |
| EV/EBITDA | -20.38 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Last Dividend Ex-Date | Mar 28, 2018 |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Amylyx Pharmaceuticals at a Glance
As of the Oct 23, 2026 close, Amylyx Pharmaceuticals (AMLX) has a market capitalization of $3.02B. Revenue fell 100.0% year over year.
As of its latest reported balance sheet, it holds $49.33M in cash and securities against $5.25M of debt, a net cash position of $44.07M.
Amylyx Pharmaceuticals does not currently pay a dividend.
The share price is up 99.7% over the past year. At $27.20 (the Oct 23, 2026 close) it sits within its 52-week range of $10.83 to $41.14, above its 200-day moving average of $19.44.
Based on 10 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $46.63, 71.4% above the Oct 23, 2026 close.
Frequently Asked Questions About Amylyx Pharmaceuticals
What is the current stock price for AMLX?
As of the Oct 23, 2026 close, AMLX stock trades at $27.20. The 52-week range is $10.83–$41.14, with a day range of $27.06–$28.46.
What is the P/E ratio for AMLX?
The P/E ratio (Price-to-Earnings) for AMLX is shown in the Key Statistics section. This valuation metric helps compare Amylyx Pharmaceuticals, Inc. to industry peers.
Does AMLX pay dividends?
Amylyx Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for AMLX?
Based on ratings from 10 professional analysts over the last 90 days, the consensus for AMLX is Buy. The average 12-month price target is $46.63, a 71.4% upside from the Oct 23, 2026 close of $27.20.
What is the market cap of AMLX?
As of the Oct 23, 2026 close, Amylyx Pharmaceuticals's market capitalization is $3.02B, classifying it as a mid-cap company. Amylyx Pharmaceuticals operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.